FDA FINANCIAL DISCLOSURE REG WOULD NOT APPLY TO PRECLINICAL
This article was originally published in The Gray Sheet
Executive Summary
FDA FINANCIAL DISCLOSURE REG WOULD NOT APPLY TO PRECLINICAL or manufacturing and controls studies, according to the agency's proposed rule, "Financial Disclosure by Clinical Investigators," published in the Federal Register Sept. 22. "FDA has tentatively chosen not to seek information on investigators carrying out preclinical or manufacturing and controls operations," the notice states.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.